ARCHIVES

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

This article is from The Cancer Letter archive.

Vol. 07 No. 03 | January 16, 1981

Download PDF Visit The Full Archive

Related Articles

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

NCCS Networker Volume 3 Issue 3, Summer 1989

June 13, 1989

Toxicology Program Board To Review Nine Substances.

January 14, 2000

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

Conferees Set NIH Funding At $30 Billion.

November 2, 2007

NCI Cooperative Group, Cancer Center Trials Listed

October 28, 2005